Aspirin may improve 3-month survival for patients critically ill with COVID-19, Imperial College London

Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months.

Source: Current Awareness Service for Health (CASH) - March 24, 2022 Category: Consumer Health News Source Type: news